ARCHIVES

Funding Opportunities: ONS Biotherapy Phase II, Outcomes-Research Grant

This article is from The Cancer Letter archive.

Vol. 27 No. | August 3, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Simone Moves To huntsman Foundation, Golde Names MSK Physician-In-Chief

January 26, 1996

In Brief: Progress Reported In NCI-FDA Fight Over New Drug Tests, Epidemiology Branch Reorganized

December 12, 1975

High Response Rate of Hairy Cell Leukemia Patients to Immunotoxin Treatment In Phase I

April 27, 2001

IOM Report Urges DOD, VA, Congress To End Tobacco Use In Military.

July 10, 2009

NCI-Approved Clinical Trials

February 24, 2006

Two Phase III Afatinib Trials Demonstrate Prolonged Survival

May 30, 2014